Clinical significance of O-6-methylguanine-DNA-methyltransferase promoter methylation in patients with esophageal carcinoma: A systematic meta-analysis
Digestive Diseases | Jan 04, 2018
Zhang Y, et al. - The researchers perform this meta-analysis to assess the clinical effect of O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation on esophageal carcinoma patients. Collected evidence represented that MGMT promoter methylation could be associated with esophageal cancer carcinogenesis and might be correlated with age, lymph node status, and clinical stage.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
